NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Animerra

Animerra

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.animol-discovery.com/

Last Round

Series C

Feb 3, 2025

Est. Valuation

$99.5M

Total Funding Raised

$44.5M

Company Overview

Animol Discovery is a biotechnology company developing animal drug discovery technology to discover small-molecule active pharmaceutical ingredients.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

animal healthdrug discoverysmall-molecule discoveryAI drug discoveryveterinary medicineanimal health biotechdrug discovery platformveterinary pharmaceuticalsDNA-encoded librariespet pharmaanimal pharmahigh throughput screeningcomputational chemistrycompanion animal healthlivestock healthDEL screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Animerra Comps

Public and private peers based on sector, stage, and business model.

Animerra comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Animerra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 3, 2025
Series BJul 28, 2022

Key People

Founding team and executive leadership

Anna Rath

Founder, CEO and Board Member

Founding Team

Animerra Investors

Notable investors and investment history

Animerra investors
InvestorRounds
Anterra CapitalSeries B, Accelerator
Novalis LifeSciencesSeries C, Series B
Finistere VenturesSeries B, Series C

Animerra Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Animerra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Animerra's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range10
Year Founded2019
Last FundingFeb 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.